aTyr Pharma Secures $49,000,000 New Financing

  • Feed Type
  • Date
    7/29/2013
  • Company Name
    aTyr Pharma
  • Mailing Address
    3565 General Atomics Court San Diego, CA 92121
  • Company Description
    We have developed proprietary methods for discovering Physiocrines, extracellular proteins that are derived from the tRNA synthetase family of enzymes, and which were predominantly overlooked by other genomic and secretome discovery efforts.
  • Website
    http://www.atyrpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $49,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The financing supports the clinical development of aTyr’s first therapeutic program to treat rare autoimmune diseases and a rare disease pipeline in immune disorders.
  • M&A Terms
  • Venture Investor
    Alta Partners
  • Venture Investor
    Cardinal Partners
  • Venture Investor
    Domain Associates
  • Venture Investor
    Polaris Partners

By posting a comment, you agree to our terms and conditions.